Mesoblast (MESO) Net Margin Growth (5y) (2019 - 2023)
Mesoblast (MESO) Net Margin Growth (5y) (2019 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Mesoblast | 2.01 Bn | 1.87 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 4,391.00 |
| Mar 31, 2023 | 117,364.00 |
| Dec 31, 2022 | -137,968.00 |
| Sep 30, 2022 | -16,276.00 |
| Jun 30, 2022 | 384,552.00 |
| Mar 31, 2022 | 199,823.00 |
| Dec 31, 2021 | 389,698.00 |
| Sep 30, 2021 | 454,924.00 |
| Jun 30, 2021 | -128,487.00 |
| Mar 31, 2021 | -91,437.00 |
| Dec 31, 2020 | -55,128.00 |
| Jun 30, 2020 | 69,086.00 |
| Mar 31, 2020 | -14,048.00 |
| Dec 31, 2019 | -50,523.00 |
| Sep 30, 2019 | 12,147.00 |